explore -WSS

explore

author：entertainment 2025-10-02 22:25:07 - browse：25

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： What PEPFAR has meant on the ground in Ukraine

WSS

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

AI models in health care face new federal disclosure requirements

Teach medical students about patients with intellectual disabilities

Spinal cord stimulation reduces pain in amputees, study finds

SCOTUS to consider access to abortion pill mifepristone

Why age limits for politicians are a terrible idea

hotspot

explore

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Patients' immediate access to test results puts radiologists in a bind

Moonlake's readout produced a cash windfall. Risks remain

Senate panel eyes new effort on drug shortages

Medical records are filled with copy

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Supreme Court strikes down use of affirmative action

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Medical leaders decry Supreme Court decision on affirmative action

When women are denied an abortion, their children fare worse than peers

focus

When women are denied an abortion, their children fare worse than peers

A Q&A with the global head of Boehringer Ingelheim's innovation unit

SCOTUS to consider access to abortion pill mifepristone

The future of health care in the House

Phenylephrine and the overlooked value of the placebo effect

AI models in health care face new federal disclosure requirements

entertainment

Wikipedia

knowledge

focus